High doses of saw palmetto appear safe over 18 months

High doses of saw palmetto appear safe over 18 months
Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

(HealthDay)—Extracts of saw palmetto berry used at doses of up to 960 mg daily appear to be safe over an 18-month period, according to a study published in the April issue of The Journal of Urology.

Noting that saw palmetto berry extracts are used as self-treatment for lower urinary tract symptoms associated with , Andrew L. Avins, M.D., M.P.H., from Northern California Kaiser-Permanente Division of Research in Oakland, and colleagues examined the safety of saw palmetto extract among 357 men participating in the for Urological Symptoms trial. During 18 months of follow-up, participants were randomized to receive 320, 640, and 960 mg daily of an ethanolic saw palmetto extract in an escalating manner at six-month intervals or to an identical-appearing placebo.

The researchers found that there were no significant between-group differences in the rates of serious or non-, changes in vital signs, findings on digital prostate examination, or rates of study withdrawal. There were also no significant differences in laboratory test abnormalities between the groups. Differences in individual laboratory tests were small in magnitude and occurred rarely. There was no evidence of a dose-response effect of saw palmetto.

"Our data suggest that saw palmetto is unlikely to be associated with important, common toxicity for up to 18 months," write the authors. "While the most recent clinical evidence does not support the superiority of saw palmetto over placebo, it appears that men who elect to try the supplement are unlikely to have substantial adverse medical consequences from short-term use."

Placebo and saw palmetto extract were provided by Rottapharm/Madaus. One author disclosed to the Informed Medical Decisions Foundation.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

High doses of saw palmetto don't impact serum PSA

Feb 08, 2013

(HealthDay)—Compared with placebo, saw palmetto, even at a dose as high as 960 mg, does not affect serum prostate-specific antigen (PSA) levels in men with lower urinary tract symptoms, according to research ...

Latrepirdine not effective in Huntington's disease

Nov 01, 2012

(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease ...

Belimumab deemed safe for long-term lupus treatment

Jun 19, 2012

(HealthDay) -- For patients with systemic lupus erythematosus (SLE), long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 in Arthritis & ...

Recommended for you

Two expats die of MERS in Saudi commercial hub

23 hours ago

Two foreigners died of MERS in the Saudi city of Jeddah, the health ministry said Saturday, as fears rise over the spreading respiratory virus in the kingdom's commercial hub.

UAE reports 12 new cases of MERS

23 hours ago

Health authorities in the United Arab Emirates have announced 12 new cases of infection by the MERS coronavirus, but insisted the patients would be cured within two weeks.

Filipino tests negative for Middle East virus

Apr 19, 2014

A Filipino nurse who tested positive for the Middle East virus has been found free of infection in a subsequent examination after he returned home, Philippine health officials said Saturday.

User comments